Results 101 to 110 of about 3,206 (156)

Safety and activity of PD-1 blockade-activated DC-CIK cells in patients with advanced solid tumors. [PDF]

Oncoimmunology, 2018
Chen CL, Pan QZ, Weng DS, Xie CM, Zhao JJ, Chen MS, Peng RQ, Li DD, Wang Y, Tang Y, Wang QJ, Zhang ZL, Zhang XF, Jiang LJ, Zhou ZQ, Zhu Q, He J, Liu Y, Zhou FJ, Xia JC.   +19 more
europepmc   +1 more source

Safety and efficacy of cytokine-induced killer cells for gastric cancer: a systematic review and meta-analysis. [PDF]

Front Oncol
Zhu M, Yang C, Liang B, Liu Q.
europepmc   +1 more source

Recombinant Adenovirus KGHV500 and CIK Cells Codeliver Anti-p21-Ras scFv for the Treatment of Gastric Cancer with Wild-Type Ras Overexpression. [PDF]

Mol Ther Oncolytics, 2018
Wang M, Hong Y, Feng Q, Pan X, Song S, Cui J, Lei J, Fang H, Yang J.   +8 more
europepmc   +1 more source

CIK cells – current status, clinical perspectives and future prospects – the good news [PDF]

Expert Opinion on Biological Therapy, 2012
openaire   +2 more sources

First-in-Human Study of IL15-Activated Cytokine-Induced Killer Cells After Allogeneic HCT Shows Durable Remission and Serotherapy-Associated Immune Reconstitution in Leukemia. [PDF]

J Clin Oncol
Rettinger E, Heckl D, Hutter M, Salzmann-Manrique E, Luedtke M, Huenecke S, Bremm M, Cappel C, Bug G, Greil J, Meisel R, Wagner-Drouet EM, Serve H, Güngör T, Klusmann JH, Klingebiel T, Bader P, Bonig H.   +17 more
europepmc   +1 more source

Therapeutic potential of cytokine-induced killer cell therapy for renal cell carcinoma and prostate cancer. [PDF]

Cell Commun Signal
Lee IT, Wang YL, Hong JH, Huang CY, Vo TTT, Lee WJ, Chiang CH.   +6 more
europepmc   +1 more source

Efficacy of modified dendritic cell-cytokine-induced killer cells loaded with tumour stem cell membrane microparticle therapy in the treatment of relapsed or refractory T- and NK-cell lymphoid proliferations and lymphomas: a report of three cases. [PDF]

Ann Hematol
Wang A, Fan T, Zhang J, Ye M, Huang H, Gao ZL.   +5 more
europepmc   +1 more source

Non-Genetically Modified Adoptive Cell Therapies for Solid Tumors: Current Landscape and Future Challenges. [PDF]

Cancer Immunol Immunother
Luo Q, Jiang W, Xie Y, Dai Z, Zhu J, Du Y, Tao X, Lei Z, Chu X, Wang B, Fu G.   +10 more
europepmc   +1 more source